The site manufactures oral drug drug product to 8 different countries and regions. It offers oral solid drug product manufacturing, along with packaging and labeling capabilities.
In the next 2-3 years, we plan to double the current manufacturing and packaging capacities. The site will also add injectable manufacturing lines, lipid nanoparticle capabilities, and spray dried dispersion to support new modalities such as oligonucleotide and peptide drug product manufacturing.
Our Couvet site has successfully passed numerous inspections by the US FDA, Japan’s PMDA, and SwissMedic.
